Biostar Pharmaceuticals, Inc. (BSPM)

[v80alue]

BSPM, Just finished listening CC. Couple positives

1) Oct revenue is 8.9m, Nov is better. So they are on track to reach guidance of 28m for Q4 and 80m for 2010.
2) Ad spending will be in line of 20-22% Rev normal around 4m for Q4
3) Plan for Big 4 auditor in 2011.
4) Guidance for 2011 will be in next several months(?) rough guidance is 30%.
5) Addressed low interest issue(raised by shorties). Only 25% real money sitting in the bank to collect low national rate.
6) Pharmaceutical companies including BSMP will not be impacted by high inflation etc.

Anyone hear differently ? PPS should recover some...